The Office of the Human Research Protection Program (OHRPP) is the administrative arm of the UCLA Human Research Protection Program (HRPP). The OHRPP in partnership with the research community is responsible for ensuring the safety and welfare of participants in Human Research Projects conducted under the aegis of UCLA. The OHRPP, which is a Division within the Office of Research Administration, provides the campus and the five UCLA Institutional Review Boards (IRBs) with professional guidance and administrative support.

COVID-19 Information/Updates

UCLA began Phase 3 of the ramp-up plan on March 15, 2021

Phase 3 introduces no changes to clinical trials and human subjects research, which continue to rely on the expertise of department chairs and deans in balancing the potential benefits of the research to the patient or participant with the infection risks. However, as with laboratory research, all current Phase 2 ROPs for human subjects research performed in non-clinical spaces will be voided on March 31, 2021 and must be replaced by an approved Phase 3 ROP.

Conducting Research During the COVID-19 Public Health Outbreak: All researchers should review the information provided on the UCLA Research Ramp Up website to determine whether and how current Policy may affect their IRB approved or exempt research. Information includes:

  1. an overview of the ramp-up process,
  2. health and safety guidelines, and
  3. appendices describing requirements for different types of research.

COVID-19 and Human Subjects Research FAQ
OHRPP Research Ramp-Up FAQ
OHRPP COVID-19 Information/Updates

    Human Research News and Other Announcements

    Posted On 5/3/2021

    BruinIRB Phase I

    OHRPP new IRB submission system, named BruinIRB, is live ... Read More

    Posted On 3/29/2021

    Updated OHRPP Guidance, and Upcoming "Learn at Lunch" on March 31, and on April 6

    Welcome OHRPP’s newest additions ... Read More

    Posted On 2/23/2021

    Updated OHRPP Guidance and OHRPP’s Upcoming "Learn at Lunch" on Thursday, February 25

    Updated OHRPP Guidance ... Read More

    Go to Human Research News